Posters/Exhibits > Session
POSTER SESSION 1 & EXHIBIT RECEPTION
Presentations
 |
(100) APPROACH TO RESOLVING T CELL SUBSET ASSAYS FLAGGED FOR DIRECTOR REVIEW: A SINGLE-CENTER EXPERIENCE Tori Catey, Valerie Miller, Dick Hwang, Jonathan Fromm, Sindhu Cherian, Fabienne Lucas. University of Washington, Department of Laboratory Medicine and Pathology, Seattle, WA, USA |
|||
|
|
(101) DEVELOPMENT OF A DRIED-DOWN 14-COLOR COCKTAIL IMPROVES WORKFLOW EFFICIENCY AND PRODUCES CONSISTENT RESULTS FOR SPECTRAL FLOW CYTOMETRY Qing Chang1, Qing Chen2, Juan Miao2, Junwei Xin2, Emily Bui1, Jun Deng1. 1Cytek Biosciences, Inc., Fremont, CA, USA 2Cytek Biosciences China, Wuxi, China |
|||
|
|
(102) NON-NEGATIVE MATRIX FACTORIZATION FOR AUTOMATED MULTIPLE AUTOFLUORESCENCE EXTRACTION IN SPECTRAL FLOW CYTOMETRY Dustin DeMeo, Jean Oak, Erik Ames, Aaron Wilk. Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA |
|||
|
|
(103) VALIDATION OF A 29-COLOR 31 ANTIGEN SINGLE-TUBE FLOW CYTOMETRIC ASSAY FOR INTEGRATED B, T, AND HODGKIN LYMPHOMA EVALUATION Sary El Daker, Jennifer Reminick, Xiaotian Sun, Qi Gao, Roshal Mikhail. Memorial Sloan Kettering Cancer Center, New York, NY, USA |
|||
|
|
(104) VALIDATION OF A 10-COLOR FLOW CYTOMETRY ASSAY INCORPORATING CD48 TO ENHANCE THE DIAGNOSTIC ACCURACY AND MINIMAL RESIDUAL DISEASE (MRD) DETECTION OF T-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA (T-ALL) Sheryll Gamatan, Jenny Li Bei, Ling Yang, Cheryl Lim, Eunice Lai, Stephrene Chan, Te Chih Liu, Shir Ying Lee. Division of Haematology, Department of Laboratory Medicine, National University Hospital, Singapore, Singapore |
|||
|
|
(105) TRANSFER AND VALIDATION OF THE OZETTE PIP-01 48-MARKER IMMUNE PROFILING PANEL AT CERBA RESEARCH FOR GLOBAL CLINICAL TRIALS Sanaz Koosha1, Manpreet Singh1, Matthias De Decker1, Amber Baele1, Eva Van Lombergen1, Bieke Soen1, Nithianandan Selliah1, Kirsteen Maclean2, Kurt VanGunst2, Denise Allen2, George Duma2, Arpan Neupane2, Cherie Green2. 1Cerba Research, New Hyde Park, NY, USA 2Ozette Technologies, Inc, Seattle, WA, USA |
|||
|
|
(106) EMERGENCY HEMATOPOIESIS: DISTINGUISHING THE NORMAL FROM THE ABNORMAL THROUGH PROPOSED CRITERIA USING FLOW CYTOMETRY Angeliki Kotsiafti1, Georgios Oudatzis1, Maroula Milaiou1, Aikaterini Mandaraka1, Paraskevi Vasileiou2, Georgios Paterakis1. 1Department of Immunology, Athens General Hospital “G. Gennimatas”, Athens, Greece 2«Flowdiagnosis» Diagnostic Center, Athens, Greece |
|||
|
|
(107) EVALUATION OF INTERACTING CELLS IN PERIPHERAL BLOOD BY FLOW CYTOMETRY: AN UNDERSTUDIED ATTRIBUTE OF HUMAN BIOLOGY Chip Lomas, Scott Bornheimer, Aaron Middlebrook. Waters Biosciences, Milpitas, CA, USA |
|||
|
|
(108) STUDY OF MANUAL VS. AUTOMATED COCKTAIL PREPARATION USING ASSAYMATE COCKTAIL PREP WORKSTATION FOR SPECTRAL FLOW CYTOMETRY. David PILLON1, Lu Wen2, Zayda Piedra-Quintero1, Kevin Bowditch1, Isabelle Viellard Pelve,2. 1BioLegend Inc, San Diego, CA, USA 2Revvity Health Sciences, Inc, Waltham, MA, USA |
|||
|
|
(109) THE INFLUENCING FACTORS OF HIGH-THROUGHPUT CBA METHOD FOR DETECTING CYTOKINES AND THE PERFORMANCE VERIFICATION OF THE DETECTION Liyuan Qiu, Dongchu Wang, Hui Wang. Hebei Yanda Lu Daopei Hospital, Langfang, China |
|||
|
|
(110) DEVELOPMENT OF A CD20 FLOW CYTOMETRY ASSAY IN WHOLE BLOOD FOR ANTI-CD20 THERAPY MONITORING ON BD FACSLYRIC Eugene V. Ravkov1, Patricia M. Davis1, Jenifer D. De Juan2, Swapna Gudipaty1, Garrin V. Abbott2, David P. Ng1, 3, Leo Lin1, 3. 1ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT, USA 2Immunologic Flow Cytometry, ARUP laboratories, Salt Lake City, UT, USA 3Department of Pathology, University of Utah School of Medicine, Salt Lake City, UT, USA |
|||
|
|
(111) BULK AMMONIUM CHLORIDE LYSIS FOR ROUTINE DIAGNOSTIC PLASMA CELL FLOW CYTOMETRY: A SINGLE-CENTER VALIDATION AND TWELVE-MONTH POST-IMPLEMENTATION REVIEW Laura Rodriguez-Torres1, Nour Shurbaji1, Duaa Dabbour1, Evgeniya Shin1, Kelly Heinstein1, Robert Liwski1,2. 1Nova Scotia Health Authority, Halifax, NS, Canada 2Dalhousie University, Halifax, NS, Canada |
|||
|
|
(112) VALIDATION OF A 12-COLOR FLOW CYTOMETRY ASSAY FOR QUANTITATIVE ASSESSMENT OF CD123 IN AML AND MDS Nithianandan Selliah1, Leen Catrysse2, Rowan Claeys2, Amber Baele2, Bieke Soen2. 1Cerba Research, Lake Success, NY, USA 2Cerba Research, Ghent, Belgium |
|||
|
|
(114) EXCLUSION OF IMMATURE AND DYSFUNCTIONAL GRANULOCYTES IMPROVES DIAGNOSTIC SPECIFICITY OF NEUTROPHIL OXIDATIVE BURST ASSAY Ananyaa Srinivasan, Jean Oak, Aaron Wilk. Department of Pathology, Stanford University School of Medicine, Palo Alto, CA, USA |
|||
|
|
(115) CLL/SLL WITH ATYPICAL IMMUNOPHENOTYPE: AN INTEGRATED DIAGNOSTIC APPROACH Wei J. Wang1, Wei Wang2. 1City of Hope National Medical Center, Duarte, CA, USA 2MD Anderson Cancer Center, Houston, TX, USA |
|||
|
|
(116) VERIFICATION OF CD40 LIGAND CLINICAL FLOW CYTOMETRY ASSAY FROM FACSCANTO II TO FACSLYRIC. Casey B Wells, Xiaomeng Ren, Miguel FS Ventura, Rebecca A Marsh. Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA |
|||
|
|
(118) UTILITY OF NATURAL KILLER (NK)-CELL RECEPTOR EXPRESSION ON γΔ T-CELLS IN DIFFERENTIATING REACTIVE AND NEOPLASTIC γΔ T-CELL POPULATIONS Valerie A Woodings, Orrin Koepke, Jason E Love, Alireza Torabi, Jonathan R Fromm, Sindhu Cherian, Afshin Shameli. Department of Laboratory Medicine and Pathology, University of Washington, Seattle, WA, USA |
|||
|
|
(119) ASSAY TRANSFER OF TWO TUBE 12-COLOR T-CELL FUNCTION PANELS ADAPTED TO INCLUDE CAR DETECTION USING A BD FACSLYRIC™ FLOW CYTOMETER Yang Zeng, Farzad Oreizy, Angela Chen, Chih-Hung Lai, Rodrigo Pestana Lopes. Waters Biosciences, Milpitas, CA, USA |
|||
|
|
(120) STANDARDIZED 35-PARAMETER MASS CYTOMETRY IMMUNE PROFILING WORKFLOW AND COHORT-DERIVED REFERENCE INTERVALS FOR HEALTHY ADULTS USING THE PLT-MC601 PLATFORM Huifang Zhao1, Man Chen2, Hui Wang1. 1Hebei Yanda Lu Daopei Hospital, Langfang, China 2Beijing Lu Daopei Hospital, Beijing, China |
|||
|
|
(121) IMPACT OF STAINING METHOD ON CD16 PERCPCY5.5 EXPRESSION Gemma Zydowsky, MLS (ASCP), Jenny Byrd, MS, SCYM (ASCP). University of Wisconsin Hospital and Clinics, Madison, WI, USA |
|||
|
|
(122) CD34 NEGATIVE ACUTE LEUKEMIA, MEDIASTINAL MASS AND TP53 MUTATION: AN AGGRESSIVE PRESENTATION OF A RARE ENTITY Shreyam Acharya, Anirban Kundu, Atoshi Basu, Sudhanya Biswas, Debmalya Bhattacharyya. Apollo Multispeciality Hospitals, Kolkata, India |
|||
|
|
(124) WHEN THE BONE MARROW IS NEGATIVE: FLOW CYTOMETRIC DIAGNOSIS OF ISOLATED CNS BLAST PHASE IN CML Charles Ehster, Brianna Cunniff-Caswell, Michael Linden, Samreen Fathima. University of Minnesota, Minneapolis, MN, USA |
|||
|
|
(125) BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM WITH LOSS OF CD303: A CHALLENGING DIFFERENTIAL DIAGNOSIS REMEDIATED WITH IRF8 FLOW CYTOMETRIC ANALYSIS Samuel F Van Buskirk, Alden E Chesney, Kyle Tripp, Rajeswari Jayakumar. Virginia Commonwealth University Health System, Richmond, VA, USA |
|||
|
|
(126) DIAGNOSTIC DILEMMA IN ACUTE LEUKEMIA Alexander Yue, Daniel Ding. Walter Reed National Military Medical Center, Bethesda, MD, USA |
|||
|
|
(127) ACUTE MYELOID LEUKEMIA MIMICKING BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM Dmitry Zlobin1,2, Carlos J Villarroel1,2, Deborah A Fuchs1,2. 1University of Arizona, Department of Pathology and Laboratory Medicine, Tucson, AZ, USA 2Banner University Medical Center, Tucson, AZ, USA |
|||
|
|
(128) 58 PARAMETER SPECTRAL CYTOMETRY FOR BROAD CLINICAL DIAGNOSTIC APPLICATION. Evangelia Williams, Elisavet Ntavli, Eduardo de Paiva Alves, McKenzie Duncan, Thomas Hayday, Adam G. Laing. IMU Biosciences, London, United Kingdom |
|||
|
|
(129) CYTOPLASMIC IMMUNOGLOBULIN LIGHT CHAIN-BASED GATING FOR PLASMA CELLS: A NO-COST ALTERNATIVE TO CD38-BASED GATING IN FLOW CYTOMETRY karthik Bommannan Bommannan Kuppuraju, Shirley Sundersingh. Cancer Institute (W.I.A), Chennai, India |
|||
|
|
(130) FLOW FEATURES OF ACUTE PROMYELOCYTIC LEUKEMIA: A SINGLE INSTITUTION QUALITY IMPROVEMENT PROJECT Mahsa Hajizadeh, Elizabeth Courville. University of Virginia Health, Charlottesville, VA, USA |
|||
|
|
(131) FLOW CYTOMETRIC IMMUNOPHENOTYPIC VARIATION IN ADULT T-CELL LEUKEMIA / LYMPHOMA. Matan Kadosh2, Luis Ascanio Cortez1, Alberto Paniz-Mondolfi1, Wei Cai1, Amy Duffield1, Shafinaz Hussein1. 1Mount Sinai Hospital, Icahn School of Medicine, New York, NY, USA 2Mount Sinai West, New York, NY, USA |
|||
|
|
(132) MEMORY-ASSISTED INTERPRETATION OF TCL1, AGAINST THE B-CELL MATURATION COMPARTMENT IN B-CELL LYMPHOPROLIFERATIVE DISORDERS GEORGIOS PATERAKIS1, ANGELIKI KOTSIAFTI1, GEORGIOS OUDATZIS1, MAROULA MILAIOU1, KATERINA MANDARAKA1, PARASKEVI VASILEIOU2. 1IMMUNOLOGY DEPARTMENT,, ATHENS, Greece 2FLOWDIAGNOSIS DIAGNOSTIC LABORATORY, ATHENS, Greece |
|||
|
|
(133) VISUALIZING MEASURABLE RESIDUAL DISEASE: BD CELLVIEW™ IMAGING CONFIRMS THE SINGLE-CELL ORIGIN OF RARE ABNORMAL PLASMA CELLS Siobhan Cashman1, Chip Lomas2, Aaron Middlebrook2, Scott Bornheimer2. 1Waters Biosciences, Limerick, Ireland 2Waters Biosciences, Milpitas, CA, USA |
|||
|
|
(134) ANALYTICAL PERFORMANCE OF AN AUTOMATED DRY TUBE WORKFLOW USING THE CELLMEK SPS SYSTEM Xizi (Daisy) Dai, Juan Fernandez De Castro, Xue Wen, Jessica Ashbaugh, Sandra Hernandez. Beckman Coulter Life Sciences, Miami, FL, USA |
|||
|
|
(135) A FLEXIBLE CLOUD PLATFORM FOR VALIDATED FLOW CYTOMETRY WORKFLOWS Srikar Devakonda1, Santosh Putta1, Leesa Pennell1, David Soper1, Jansen Seheult2, Pedro Horna2. 1Revvity Inc., San Diego, CA, USA 2Mayo Clinic, Rochester, MN, USA |
|||
|
|
(136) MEASURABLE RESIDUAL DISEASE: POSITIVE NEXT GENERATION SEQUENCING RESULTS WITH NEGATIVE FLOW CYTOMETRY DOES NOT ALWAYS INDICATE RESIDUAL DISEASE. Tanvi/YP Verma, Xueyan Chen, Emily/H Glynn, Cecilia/CS Yeung, Sindhu Cherian, Kerstin Edlefsen. University of Washington, Seattle, WA, USA |
|||
|
|
(137) DEVELOPMENT AND VALIDATION OF THE BD HORIZON REALDYE™ PORTFOLIO FOR CONVENTIONAL AND SPECTRAL FLOW CYTOMETRY: COMBINING ADVANCED FLUOROCHROME PERFORMANCE WITH MANUFACTURING EXCELLENCE Lorena Hidalgo1, Feng-Jun Luan1, Jessica Stokes1, Andrea Nguyen1, Hyunji Do1, Saloni Desai1, Stephanie Widmann1, Peter Mage2, Jacob Rabenstein1. 1Waters Biosciences, San Diego, CA, USA 2Waters Biosciences, Milpitas, CA, USA |
|||
|
|
(138) CAN A NOVEL STABILIZING REAGENT PRESERVE EX-VIVO PLATELET ACTIVATION STATES FOR SEVEN-DAY DELAYED FLOW CYTOMETRY ANALYSIS? Yuqian Hua1, Kelvin Liu2, Xingzhou Liu2, Zhaohui Wang2. 1IntelliFlow (Beijing) Biotechnology Co., Ltd., Beijing, China 2Gene tech ents Ltd., Princeton, NJ, USA |
|||
|
|
(139) AUTOMATED FLOW CYTOMETRY SAMPLE PREPARATION: VALIDATION OF WASH/STAIN/LYSIS/WASH PROTOCOL ON CELLMEK SAMPLE PREPARATION SYSTEM Taruna Jagtiani1, Yijie Liu1,2, Jeffrey Wilks1. 1Clinical Flow Cytometry Laboratory, Department of Pathology, Northwestern Memorial Hospital, Chicago, IL, USA 2Department of Pathology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA |
|||
|
|
(140) SINGLE RNA MOLECULE DETECTION IN INTACT CELLS BY FLOW CYTOMETRY USING THE SUPERRCA ASSAY Josefine Lustig1, Sofie Kelleway2, Lei Chen1, Amey Mukim1. 1Rarity Bioscience AB, Uppsala, Sweden 2University of Nottingham, Nortingham, United Kingdom |
|||
|
|
(141) ULTRA-SENSITIVE FMC63 CAR-T MONITORING USING THE SUPERRCA ASSAY Amey Mukim, Thomas Edgren, Lei Chen. Rarity BIoscience, Uppsala, Sweden |
|||
|
|
(142) A LABEL-FREE FOUNDATION MODEL FOR AUTOMATED VIABILITY ASSESSMENT AND FUNCTIONAL ASSAYS IN IMAGING FLOW CYTOMETRY Keegan Owsley1, Greg Fields1, Siobhan Cashman2, Seamus Hickey2. 1Waters Biosciences, Milpitas, CA, USA 2Waters Biosciences, Limerick, Ireland |
|||
|
|
(143) ULTRA‑SENSITIVE SUPERRCA ASSAY ENABLES DETECTION OF KIT D816V BEYOND DDPCR Natalia Sigal1, Andrew Dixon1, Erik Kish-Trier1, Mark Rosenzweig 2, Guang Yang2, Rentian Wu2, Rachel L Erlich2, Lei Chen3, Sara Bodbin3, Tracy I George1, Leo Lin1, Peng Li1. 1ARUP Laboratories, Salt Lake City, UT, USA 2Blueprint Medicines, Cambridge, MA, USA 3Rarity Bioscience, Uppsala, Sweden |
|||
|
|
(144) CLINICAL VALIDATION AND IMPLEMENTATION OF A CUSTOM AUTOMATION PLATFORM FOR CLINICAL FLOW CYTOMETRY SPECIMEN PREPARATION Xiaotian Sun1, Sary EI Daker1, Brian Murphy2, Mohamad Haque3, Jennifer Reminick1, Qi Gao1, Mikhail Roshal1. 1Hematopathology Service, Department of Pathology and Laboratory Medicine,Memorial Sloan Kettering Cancer Center, New York, NY, USA 2Pathology Automation, Department of Pathology and Laboratory Medicine,Memorial Sloan Kettering Cancer Center, New York, NY, USA 3Bioinformatics, Memorial Sloan Kettering Cancer Center, New York, NY, USA |
|||
|
|
(145) IMPLEMENTING AUTOMATED TISSUE DISSOCIATION IN CLINICAL FLOW CYTOMETRY: IMPROVED CELL RECOVERY AND DIAGNOSTIC YIELD Helena Varela de Araujo, Bruce Loewen, Jing-Ping Zhang, Dionicy Tarantino, Ryan Labonte, Bartosz Grzywacz. Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA |
|||
|
|
(146) DETECTOR SETTING INDEPENDENT (DSI) SCALING ON THE BD FACSDISCOVER™ A7 CELL ANALYZER Joshua Welsh, Tri Le, Chip Lomas, Aaron Middlebrook. Waters Biosciences, Milpitas, CA, USA |
|||
|
|
(147) AUTOMATED SAMPLE PREPARATION FOR 25-COLOR FLOW CYTOMETRIC IMMUNOPHENOTYPING OF HUMAN PBMCS Yan Lu1, Xiaohuan Wang1, Ming Lei1, Alex Ko2, Garret Guenther2, Peifang Ye1, Nancy Li2. 1Agilent Biosciences (Hangzhou) Co., Ltd., Hangzhou, China 2Agilent Technologies Inc., La Jolla, CA, USA |